Kidney Disease FAQs

At Stem Cell Mexico, stem cell treatment for kidney disease is quoted individually, and the exact figure is confirmed after a medical evaluation.

At Stem Cell Mexico, stem cell treatment for kidney disease is a minimally invasive process built around an intravenous (IV) infusion of allogeneic mesenchymal stromal cells (MSCs) derived exclusively from Wharton's jelly (donated umbilical cord tissue).

Stem cell treatment for kidney disease at Stem Cell Mexico usually takes two to three days in Tijuana, including laboratory tests and your in-person evaluation, the treatment with a night at our facilities under nursing and medical monitoring, and discharge.

No. Stem cell therapy does not cure kidney disease, and chronic kidney disease (CKD) is managed over a lifetime with medications, diet and monitoring.

Stem cell therapy for kidney disease is effective as a supportive treatment: research shows that mesenchymal stem cells (MSCs) can reduce inflammation and protein leakage in the urine, a marker strongly linked to the risk of kidney disease progression, with a reassuring safety profile.

Stem cell therapy with mesenchymal stromal cells (MSCs) given by intravenous (IV) infusion has a generally favorable safety profile in clinical research, and small randomized trials in chronic kidney disease (CKD) have not identified specific safety concerns.